Cargando…

Establishing targets for advanced HIV disease: A call to action

The World Health Organization (WHO) has published a guideline for the management of individuals with advanced HIV disease (AHD) to reduce HIV-related deaths. The guideline consists of a package of recommendations including interventions to prevent, diagnose and treat common opportunistic infections,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Meya, David B., Tugume, Lillian, Nabitaka, Vennie, Namuwenge, Proscovia, Phiri, Sam, Oladele, Rita, Jibrin, Bilkisu, Mobolaji-Bello, Mojisola, Kanyama, Cecilia, Maokola, Werner, Mfinanga, Sayoki, Katureebe, Cordelia, Amamilo, Ikechukwu, Ngwatu, Brian, Jarvis, Joseph N., Harrison, Thomas S., Shroufi, Amir, Rajasingham, Radha, Boulware, David, Govender, Nelesh P., Loyse, Angela
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AOSIS 2021
Materias:	Opinion Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8424734/ https://www.ncbi.nlm.nih.gov/pubmed/34522428 http://dx.doi.org/10.4102/sajhivmed.v22i1.1266

Ejemplares similares

High acceptability and viral suppression of patients on Dolutegravir-based first-line regimens in pilot sites in Uganda: A mixed-methods prospective cohort study
por: Nabitaka, Vennie Mbaziira, et al.
Publicado: (2020)

Results from a proactive follow-up intervention to improve linkage and retention among people living with HIV in Uganda: a pre-/post- study
por: Boeke, Caroline E., et al.
Publicado: (2018)

Adherence of health workers to guidelines for screening and management of cryptococcal meningitis in Uganda
por: Namuju, Olivie C., et al.
Publicado: (2023)

Assessing linkage to and retention in care among HIV patients in Uganda and identifying opportunities for health systems strengthening: a descriptive study
por: Boeke, Caroline E., et al.
Publicado: (2018)

Induction-phase treatment costs for cryptococcal meningitis in high HIV-burden African countries: New opportunities with lower costs
por: Larson, Bruce, et al.
Publicado: (2022)

A prospective cohort study of outcomes for isoniazid prevention therapy: a nested study from a national QI collaborative in Uganda
por: Sensalire, Simon, et al.
Publicado: (2020)

Histoplasmosis in Children; HIV/AIDS Not a Major Driver
por: Ekeng, Bassey E., et al.
Publicado: (2021)

Cryptococcal meningitis: A neglected NTD?
por: Molloy, Síle F., et al.
Publicado: (2017)

A qualitative evaluation of an implementation study for cryptococcal antigen screening and treatment in Uganda
por: Lofgren, Sarah M., et al.
Publicado: (2018)

Erratum to: The Changing Epidemiology of HIV-Associated Adult Meningitis, Uganda 2015–2017
por: Ellis, Jayne, et al.
Publicado: (2019)

The Changing Epidemiology of HIV-Associated Adult Meningitis, Uganda 2015–2017
por: Ellis, Jayne, et al.
Publicado: (2019)

Cryptococcal Meningitis Treatment Strategies in Resource-Limited Settings: A Cost-Effectiveness Analysis
por: Rajasingham, Radha, et al.
Publicado: (2012)

Nosocomial Drug-Resistant Bacteremia in 2 Cohorts with Cryptococcal Meningitis, Africa
por: Rajasingham, Radha, et al.
Publicado: (2014)

Performance of Cryptococcal Antigen Lateral Flow Assay Using Saliva in Ugandans with CD4 <100
por: Kwizera, Richard, et al.
Publicado: (2014)

S7.1d Reliability of bedside point-of-care tests for Candida neoformans , M. tuberculosis and S. pneumoniae in adults living with HIV presenting with suspected central nervous system infection (CNS) in low- and middle-income settings: Preliminary results from the DREAMM study
por: Leclere, Aude Sturny, et al.
Publicado: (2022)

Cryptococcal Antigenemia in Human Immunodeficiency Virus Antiretroviral Therapy–Experienced Ugandans With Virologic Failure
por: Mpoza, Edward, et al.
Publicado: (2019)

P449 Semi-quantitative cryptococcal antigen rapid test (CryptoPS, Biosynex®) for cryptococcal meningitis in patients living with HIV in Sub-Saharan Africa: prospective multicenter diagnostic accuracy study (DREAMM)
por: Leclere, Research Engineer Aude Sturny, et al.
Publicado: (2022)

Effectiveness of provider-initiated versus client-initiated HIV testing by different health facility departments in Northern Tanzania
por: Abdul, Ramadhani, et al.
Publicado: (2023)

Evaluation of a national cryptococcal antigen screening program for HIV-infected patients in Uganda: A cost-effectiveness modeling analysis
por: Rajasingham, Radha, et al.
Publicado: (2019)

A Model for Accelerating Access to Care and Treatment for Children and Adolescents Living with HIV in Nigeria, Tanzania, Uganda, and Zambia: The Faith-Based Action for Scaling-Up Testing and Treatment for the Epidemic Response (FASTER) Initiative
por: Oliver, Daniel, et al.
Publicado: (2023)

Baseline Serum C-Reactive Protein Level Predicts Mortality in Cryptococcal Meningitis
por: Chesdachai, Supavit, et al.
Publicado: (2020)

2120. Minimum Inhibitory Concentration Distribution of Fluconazole against Cryptococcus Species and the Fluconazole Exposure Prediction Model
por: Chesdachai, Supavit, et al.
Publicado: (2019)

Over-the-counter suboptimal dispensing of antibiotics in Uganda
por: Mukonzo, Jackson K, et al.
Publicado: (2013)

Healthcare Costs and Life-years Gained From Treatments Within the Advancing Cryptococcal Meningitis Treatment for Africa (ACTA) Trial on Cryptococcal Meningitis: A Comparison of Antifungal Induction Strategies in Sub-Saharan Africa
por: Chen, Tao, et al.
Publicado: (2019)

Addition of Flucytosine to Fluconazole for the Treatment of Cryptococcal Meningitis in Africa: A Multicountry Cost-effectiveness Analysis
por: Shiri, Tinevimbo, et al.
Publicado: (2020)

Short-term Mortality Outcomes of HIV-Associated Cryptococcal Meningitis in Antiretroviral Therapy–Naïve and –Experienced Patients in Sub-Saharan Africa
por: Kalata, Newton, et al.
Publicado: (2021)

Understanding Uganda’s early adoption of novel differentiated HIV treatment services: a qualitative exploration of drivers of policy uptake
por: Zakumumpa, Henry, et al.
Publicado: (2023)

Minimum Inhibitory Concentration Distribution of Fluconazole Against Cryptococcus Species and the Fluconazole Exposure Prediction Model
por: Chesdachai, Supavit, et al.
Publicado: (2019)

Smear microscopy and culture conversion rates among smear positive pulmonary tuberculosis patients by HIV status in Dar es Salaam, Tanzania
por: Senkoro, Mbazi, et al.
Publicado: (2010)

Routine Cryptococcal Antigen Screening in Solid Organ Transplant Recipients: Is it Time to Save Lives and Money?
por: George, Ige, et al.
Publicado: (2017)

Emergomycosis in Africa: Time to Pay Attention to This Emerging Deadly Fungal Infection
por: Ibe, Chibuike, et al.
Publicado: (2023)

Preventing Cryptococcosis—Shifting the Paradigm in the Era of Highly Active Antiretroviral Therapy
por: Meya, David, et al.
Publicado: (2015)

Understanding implementation barriers in the national scale-up of differentiated ART delivery in Uganda
por: Zakumumpa, Henry, et al.
Publicado: (2020)

1472 Epidemiology of Meningitis in an HIV-infected Ugandan Cohort
por: Rajasingham, Radha, et al.
Publicado: (2014)

Hyponatremia as a Predictor of Cryptococcal Meningitis and Death Among Asymptomatic Persons With HIV and Cryptococcal Antigenemia
por: Lehman, Alice, et al.
Publicado: (2023)

Isolation, biochemical and molecular identification of Nocardia species among TB suspects in northeastern, Tanzania; a forgotten or neglected threat?
por: Hoza, Abubakar S., et al.
Publicado: (2017)

Evaluation of the effectiveness of a South African laboratory cryptococcal antigen screening programme using a retrospective cohort and a cluster-randomised trial design
por: DeSanto, Daniel J, et al.
Publicado: (2022)

AMBIsome Therapy Induction OptimisatioN (AMBITION): High dose AmBisome for cryptococcal meningitis induction therapy in sub-Saharan Africa: economic evaluation protocol for a randomised controlled trial-based equivalence study
por: Ponatshego, Ponego Lloyd, et al.
Publicado: (2019)

Evaluation of a point-of-care immunoassay test kit ‘StrongStep’ for cryptococcal antigen detection
por: Mpoza, Edward, et al.
Publicado: (2018)

Reflexive Laboratory-Based Cryptococcal Antigen Screening and Preemptive Fluconazole Therapy for Cryptococcal Antigenemia in HIV-Infected Individuals With CD4 <100 Cells/µL: A Stepped-Wedge, Cluster-Randomized Trial
por: Meya, David B., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_cm5ikohgi2hku8qbr2mgsi00fi